Medicine
Rabeprazole 20 mg delayed-release tablet
Rabeprazole 20 mg delayed-release tablet is a generic prescription medicine for oral use, made by 19 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15-30°C (59-86°F). Protect from…
Key facts
- Active ingredient (INN)
- Rabeprazole
- Brand
- Sold under the generic name
- Strength
- 20 mg
- Dosage form
- Delayed-release tablet
- Route
- Oral
- Packs
- 30 tablets, 100 pouches, 90 tablets and 105 more
- Manufacturers
- Ascend LaboratoriesIndiaAurobindo PharmaIndiaTorrent PharmaceuticalsIndiaBryant Ranch PrepackLannettAmneal PharmaceuticalsAdvagen PharmaChartwell RX19 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15-30°C (59-86°F). Protect from moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 8 November 2013
- Identifiers
- RxCUI 854868DailyMed set ID c5c43222-d167-4152-b5c7-84b55920a7ce, 951caefe-6e18-48ff-9567-beb545b09c25, 4582d443-f1be-4f94-85da-49aa603f54e4 +33NDC 62135-503, 65162-724, 68788-8536 +34Application ANDA090678, ANDA204179, ANDA204237 +3
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 19 labelers. The register lists 108 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, delayed release in 1 bottle | 67877-443-30 | Ascend LaboratoriesIndia | 27 April 2018 |
| 100 pouch in 1 carton / 1 blister pack in 1 pouch / 10 tablet, delayed release in 1 blister pack | 67877-443-38 | Ascend LaboratoriesIndia | 27 April 2018 |
| 90 tablet, delayed release in 1 bottle | 67877-443-90 | Ascend LaboratoriesIndia | 27 April 2018 |
| 30 tablet, delayed release in 1 bottle | 65862-721-30 | Aurobindo PharmaIndia | 17 February 2017 |
| 90 tablet, delayed release in 1 bottle | 65862-721-90 | Aurobindo PharmaIndia | 17 February 2017 |
| 30 tablet, delayed release in 1 bottle | 13668-107-30 | Torrent PharmaceuticalsIndia | 8 November 2013 |
| 90 tablet, delayed release in 1 bottle | 13668-107-90 | Torrent PharmaceuticalsIndia | 8 November 2013 |
| 30 tablet, delayed release in 1 bottle | 72888-059-30 | Advagen Pharma | 1 June 2017 |
| 90 tablet, delayed release in 1 bottle | 72888-059-90 | Advagen Pharma | 1 June 2017 |
| 30 tablet, delayed release in 1 bottle | 65162-724-03 | Amneal Pharmaceuticals | 1 October 2015 |
| 90 tablet, delayed release in 1 bottle | 65162-724-09 | Amneal Pharmaceuticals | 1 October 2015 |
| 1000 tablet, delayed release in 1 bottle | 65162-724-11 | Amneal Pharmaceuticals | 1 October 2015 |
| 500 tablet, delayed release in 1 bottle | 65162-724-50 | Amneal Pharmaceuticals | 1 October 2015 |
| 30 tablet, delayed release in 1 bottle | 62135-503-30 | Chartwell RX | 27 April 2023 |
| 90 tablet, delayed release in 1 bottle | 62135-503-90 | Chartwell RX | 27 April 2023 |
| 30 tablet, delayed release in 1 bottle | 62175-302-32 | Lannett | 8 November 2013 |
| 500 tablet, delayed release in 1 bottle | 62175-302-41 | Lannett | 8 November 2013 |
| 250 tablet, delayed release in 1 bottle | 62175-302-42 | Lannett | 8 November 2013 |
| 1000 tablet, delayed release in 1 bottle | 62175-302-43 | Lannett | 8 November 2013 |
| 90 tablet, delayed release in 1 bottle | 62175-302-46 | Lannett | 8 November 2013 |
| 90 tablet, delayed release in 1 bottle | 71335-0244-2 | Bryant Ranch Prepack | 1 April 2021 |
| 30 tablet, delayed release in 1 bottle | 71335-0244-3 | Bryant Ranch Prepack | 21 June 2018 |
| 60 tablet, delayed release in 1 bottle | 71335-0244-4 | Bryant Ranch Prepack | 19 June 2018 |
| 28 tablet, delayed release in 1 bottle | 71335-0244-5 | Bryant Ranch Prepack | 2 May 2022 |
| 120 tablet, delayed release in 1 bottle | 71335-0244-6 | Bryant Ranch Prepack | 2 May 2022 |
| 90 tablet, delayed release in 1 bottle | 71335-1100-2 | Bryant Ranch Prepack | 17 February 2021 |
| 30 tablet, delayed release in 1 bottle | 71335-1100-3 | Bryant Ranch Prepack | 8 February 2019 |
| 60 tablet, delayed release in 1 bottle | 71335-1100-4 | Bryant Ranch Prepack | 7 March 2019 |
| 28 tablet, delayed release in 1 bottle | 71335-1100-5 | Bryant Ranch Prepack | 2 April 2024 |
| 120 tablet, delayed release in 1 bottle | 71335-1100-6 | Bryant Ranch Prepack | 2 April 2024 |
| 90 tablet, delayed release in 1 bottle | 71335-1558-2 | Bryant Ranch Prepack | 2 May 2022 |
| 30 tablet, delayed release in 1 bottle | 71335-1558-3 | Bryant Ranch Prepack | 20 April 2020 |
| 60 tablet, delayed release in 1 bottle | 71335-1558-4 | Bryant Ranch Prepack | 8 June 2020 |
| 28 tablet, delayed release in 1 bottle | 71335-1558-5 | Bryant Ranch Prepack | 2 May 2022 |
| 120 tablet, delayed release in 1 bottle | 71335-1558-6 | Bryant Ranch Prepack | 2 May 2022 |
| 90 tablet, delayed release in 1 bottle | 71335-2304-2 | Bryant Ranch Prepack | 8 December 2023 |
| 30 tablet, delayed release in 1 bottle | 71335-2304-3 | Bryant Ranch Prepack | 8 December 2023 |
| 60 tablet, delayed release in 1 bottle | 71335-2304-4 | Bryant Ranch Prepack | 8 December 2023 |
| 28 tablet, delayed release in 1 bottle | 71335-2304-5 | Bryant Ranch Prepack | 8 December 2023 |
| 120 tablet, delayed release in 1 bottle | 71335-2304-6 | Bryant Ranch Prepack | 8 December 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 19 August 1999 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Rabeprazole 20 mg delayed-release tablet.
Clinical summary
Rabeprazole is a proton pump inhibitor indicated in adults for healing of Erosive or Ulcerative Gastroesophageal Reflux Disease (GERD), among other approved uses. It is available as delayed-release tablets for oral use. MedsAcross supplies Rabeprazole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about RabeprazoleFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Aciphex prescribing information (Waylis Therapeutics) · U.S. National Library of Medicine, DailyMed
Need Rabeprazole 20 mg delayed-release tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.